Click on image to view larger version.

Figure 2 Hazard of death, myocardial infarction, or urgent revascularization per day during the day before (–1) and days (1 to 7) after discontinuation of UFH or short-term enoxaparin. Note: by definition, day –1 (i.e., 24 h before treatment discontinuation) does not include patients who died or underwent an urgent revascularization. Abbreviations as in Figure 1.